Suppr超能文献

采用VA-ECMO治疗的难治性感染性休克的危险因素。

Risk factors for refractory septic shock treated with VA ECMO.

作者信息

Han Lei, Zhang Yan, Zhang Yonghui, Wu Wei, He Ping

机构信息

Medical and Education Department, Southwest Hospital, the First Hospital Affiliated to Army Medical University, Chongqing 400038, China.

Critical Care Medicine, Southwest Hospital, the First Hospital Affiliated to Army Medical University, Chongqing 400038, China.

出版信息

Ann Transl Med. 2019 Sep;7(18):476. doi: 10.21037/atm.2019.08.07.

Abstract

BACKGROUND

Refractory septic shock is a serious disorder with high mortality. There is currently limited evidence to support the use of extracorporeal membrane oxygenation (ECMO) in adult septic shock. We describe the outcome of patients with refractory septic shock in our hospital and try to identify prognostic factors.

METHODS

We studied a total of 23 (14 males and 9 females) refractory septic shock patients treated with venoarterial (VA) ECMO in our hospital. Clinical parameters of survival and death groups, laboratory parameters before and after ECMO placement were analyzed.

RESULTS

Eight patients were successfully weaned off ECMO and five patients were discharged. The sepsis-related organ failure assessment (SOFA) score and shock-to-ECMO interval before ECMO placement in the survival group were significantly lower than those in the death group (12.0 15.0, P=0.007; 23.5 42.2 h, P=0.037). The number of cases who had the normal range of ScvO% between the survival group and the death group at 12 h (4 4, P=0.033), 18 h (5 7, P=0.016) and 24 h (5 9, P=0.043) during ECMO was significantly different. In univariate logistic regression analysis, the case of patients with normal central venous oxygen saturation (ScvO) % at 12 h during ECMO [odds ratio (OR) 14.0, 95% confidence interval (CI): 1.200-163.367, P=0.035] was significantly associated with risk of the prognosis of patients.

CONCLUSIONS

In adult refractory septic shock patients, ScvO% at 12 h during ECMO may be a risk factor for patient prognosis.

摘要

背景

难治性感染性休克是一种死亡率很高的严重疾病。目前,支持在成人感染性休克中使用体外膜肺氧合(ECMO)的证据有限。我们描述了我院难治性感染性休克患者的治疗结果,并试图确定预后因素。

方法

我们研究了我院共23例(14例男性和9例女性)接受静脉-动脉(VA)ECMO治疗的难治性感染性休克患者。分析了生存组和死亡组的临床参数,以及ECMO置入前后的实验室参数。

结果

8例患者成功撤机,5例患者出院。生存组在ECMO置入前的脓毒症相关器官功能衰竭评估(SOFA)评分和休克至ECMO的间隔时间显著低于死亡组(分别为12.0对15.0,P = 0.007;23.5对42.2小时,P = 0.037)。在ECMO期间,生存组和死亡组在12小时(4对4,P = 0.033)、18小时(5对7,P = 0.016)和24小时(5对9,P = 0.043)时中心静脉血氧饱和度(ScvO)%处于正常范围的病例数有显著差异。在单因素逻辑回归分析中,ECMO期间12小时中心静脉血氧饱和度(ScvO)%正常的患者病例[比值比(OR)14.0,95%置信区间(CI):1.200 - 163.367,P = 0.035]与患者预后风险显著相关。

结论

在成人难治性感染性休克患者中,ECMO期间12小时的ScvO%可能是患者预后的一个危险因素。

相似文献

1
Risk factors for refractory septic shock treated with VA ECMO.
Ann Transl Med. 2019 Sep;7(18):476. doi: 10.21037/atm.2019.08.07.
3
Extracorporeal membrane oxygenation for refractory septic shock in adults.
Eur J Cardiothorac Surg. 2015 Feb;47(2):e68-74. doi: 10.1093/ejcts/ezu462. Epub 2014 Nov 25.
5
Extracorporeal life support for adults with refractory septic shock.
J Thorac Cardiovasc Surg. 2018 Sep;156(3):1104-1109.e1. doi: 10.1016/j.jtcvs.2018.03.123. Epub 2018 Apr 7.
7
Venoarterial extracorporeal membrane oxygenation support for neonatal and pediatric refractory septic shock.
Indian J Crit Care Med. 2015 Oct;19(10):600-5. doi: 10.4103/0972-5229.167038.
8
Central extracorporeal membrane oxygenation for refractory pediatric septic shock.
Pediatr Crit Care Med. 2011 Mar;12(2):133-6. doi: 10.1097/PCC.0b013e3181e2a4a1.
9
Extracorporeal membrane oxygenation support for refractory septic shock in liver transplantation recipients.
Ann Surg Treat Res. 2017 Sep;93(3):152-158. doi: 10.4174/astr.2017.93.3.152. Epub 2017 Aug 30.

引用本文的文献

2
Extracorporeal Membrane Oxygenation as Circulatory Support in Adult Patients with Septic Shock: A Systematic Review.
J Crit Care Med (Targu Mures). 2024 Apr 30;10(2):119-129. doi: 10.2478/jccm-2024-0017. eCollection 2024 Apr.
4
A Comprehensive Review of Extra Corporeal Membrane Oxygenation: The Lifeline in Critical Moments.
Cureus. 2024 Jan 31;16(1):e53275. doi: 10.7759/cureus.53275. eCollection 2024 Jan.
5
Extracorporeal membrane oxygenation in adult patients with sepsis and septic shock: Why, how, when, and for whom.
J Intensive Med. 2023 Sep 5;4(1):62-72. doi: 10.1016/j.jointm.2023.07.001. eCollection 2024 Jan.
9
Hemodynamic monitoring in patients with venoarterial extracorporeal membrane oxygenation.
Ann Transl Med. 2020 Jun;8(12):792. doi: 10.21037/atm.2020.03.186.

本文引用的文献

1
[Extracorporeal membrane oxygenation as a bridge to lung transplantation].
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Dec;30(12):1167-1172. doi: 10.3760/cma.j.issn.2095-4352.2018.012.013.
3
Extracorporeal Membrane Oxygenation for Adults With Refractory Septic Shock.
ASAIO J. 2019 Nov/Dec;65(8):760-768. doi: 10.1097/MAT.0000000000000905.
5
[Analysis on treatment of extremely severe burn patients with severe inhalation injury in August 2nd Kunshan factory aluminum dust explosion accident].
Zhonghua Shao Shang Za Zhi. 2018 Jul 20;34(7):455-458. doi: 10.3760/cma.j.issn.1009-2587.2018.07.007.
7
Extracorporeal life support for adults with refractory septic shock.
J Thorac Cardiovasc Surg. 2018 Sep;156(3):1104-1109.e1. doi: 10.1016/j.jtcvs.2018.03.123. Epub 2018 Apr 7.
8
Sepsis 2018: Definitions and Guideline Changes.
Surg Infect (Larchmt). 2018 Feb/Mar;19(2):117-125. doi: 10.1089/sur.2017.278.
9
Pathogens and outcomes in pediatric septic shock patients supported by extracorporeal membrane oxygenation.
J Microbiol Immunol Infect. 2018 Jun;51(3):385-391. doi: 10.1016/j.jmii.2017.07.012. Epub 2017 Aug 4.
10
Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: a prospective single-center study.
J Artif Organs. 2017 Sep;20(3):252-259. doi: 10.1007/s10047-017-0967-4. Epub 2017 Jun 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验